Results 181 to 190 of about 2,327,584 (298)
Thoughts and Therapies: Melanoma Brain Metastases. [PDF]
Sanghadia C +13 more
europepmc +1 more source
This review systematically summarizes the major molecular mechanisms governing TAM polarization and their coordinated interactions. It further highlights recent advances in nanoagonist‐based strategies that intervene in these pathways to reprogram TAMs, critically discussing their therapeutic potential, current limitations, and translational prospects.
Siqi Fang +7 more
wiley +1 more source
Homing exosomes following natural Blueprint for targeted drug delivery
Parental‐derived exosomes offer excellent homing, biocompatibility, and low immunogenicity. Various substances, such as chemical drugs, regulatory nucleic acids, and specific proteins, can be loaded into these exosomes for precise delivery. Then, exosomes specifically transfer the carried substances to their origin cells for targeted therapy ...
Mingliang Zhu +4 more
wiley +1 more source
Management of brain metastases in older adults with non-small cell lung cancer. [PDF]
Belone Lopes J +4 more
europepmc +1 more source
Balancing Act: Se─M bond serving as the fulcrum of the balance scale to compare the different weight of toxicity and therapeutic effects in biological environment. ABSTRACT The synthesis and characterization of organo‐selenium compounds have attracted considerable interest for decades, driven by the search for efficient catalysts and bioinspired ...
Matteo Filippi +6 more
wiley +1 more source
Opsoclonus in Pediatric Patients: Differential Diagnosis and a Practical Approach to Evaluation
ABSTRACT Opsoclonus is an ocular dyskinesia characterized by involuntary, arrhythmic, multidirectional saccades. In pediatrics, opsoclonus is most commonly attributed to the rare neuroinflammatory disorder opsoclonus‐myoclonus‐ataxia syndrome (OMAS), typically considered a paraneoplastic syndrome associated with neural crest tumors. However, opsoclonus
Aubrey C. Reed +5 more
wiley +1 more source
Alternative Lengthening of Telomeres in Cancer: Phenotypic Assessment and Therapeutic Potential
Alternative lengthening of telomeres (ALT) connects recombination‐associated telomere maintenance with measurable tumor phenotypes. Integrating phenotypic assays with tumor type and molecular background informs the evaluation of ALT for prognostic stratification and the clinical investigation of candidate therapies.
Jinkai Tong +5 more
wiley +1 more source
Cofetuzumab pelidotin (Cofe‐P) is an anti‐protein tyrosine kinase 7 (PTK7) antibody‐drug conjugate (ADC) being investigated for the treatment of adults with PTK7‐expressing, recurrent non‐small cell lung cancer (NSCLC). The first‐in‐human (FIH) trial demonstrated tolerability of dosages ≤ 2.8 mg/kg once every 3 weeks (Q3W) and ≤ 3.2 mg/kg Q2W ...
Carla Biesdorf +8 more
wiley +1 more source

